41 Small Cap Stocks Just Made New 52-Week Highs
A list of the year’s strongest stocks reveals a sharp divide in business fundamentals.
One small-cap name, HeartFlow (HTFL), has gained 102.2% over the last month alone. As of Friday, it is one of 41 Small Cap US and Canada-listed stocks trading at a 52-week high, a screen that only considers companies with a market value above $2 billion. The list is heavily weighted toward the Health Care sector, which accounts for 16 of the names.
This kind of strength raises a critical question: which of these runs are grounded in business performance, and which are not? The 10 largest names by market value are below.
The Ten Largest At New Highs
The table below shows the 10 largest of the 41 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| TWST | $8.98 Bil | 6.8% | 22.8% | 57.5% | 450.4% |
| TXG | $8.35 Bil | 2.0% | 16.1% | 35.5% | 387.4% |
| SSRM | $7.77 Bil | 2.6% | 17.3% | 39.0% | 129.8% |
| WEX | $6.94 Bil | 1.1% | 4.2% | 16.6% | 18.3% |
| VIRT | $5.85 Bil | 11.0% | 13.2% | 13.8% | 67.9% |
| SXT | $5.69 Bil | 1.5% | 0.8% | 15.4% | 20.3% |
| RELY | $5.63 Bil | 7.9% | 1.4% | 16.6% | 41.6% |
| SHC | $5.58 Bil | 1.8% | 3.6% | 11.9% | 20.1% |
| NIQ | $5.54 Bil | 3.5% | 7.6% | 80.1% | 8.7% |
| PAGP | $5.31 Bil | 0.1% | 3.9% | 2.9% | 53.4% |
Some new highs are built on profit, others on promise.
Consider the contrast between two companies on this list. SSR Mining (SSRM) trades at 33.0 times trailing earnings. Over the last twelve months, its revenue grew 48.4% and it produced an operating margin of 42.3%.
Twist Bioscience (TWST), the largest company on the list, tells a different story. Its stock has gained 57.5% over the last month. Yet over the last twelve months, its revenue grew 19.2% against an operating margin of -32.0%.
A high price is a question, not an answer.
A 52-week-high list is a useful screen for strength, and strong stocks often continue to perform. But a price is not a verdict on a business. It is simply a level the market has reached.
The disciplined next step is always the same: to check whether the underlying business fundamentals can support the new valuation. A stock at its high is the beginning of an inquiry, not the end of one.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
Strength Is A Clue. It Is Not A Plan
A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and the difference between a run that lasts and one that tops is always the business underneath.
Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the highs point; let the discipline decide.